The proposed studies with various mammalian activator cells will relate the metabolic activation and DNA binding of benzo(a)pyrene [B(a)P] and dimethylbenza(a)anthracene (DMBA).
The specific aims are: 1) To continue studies of the role of specific cytochrome P-450 induction in the binding of B(a)P and DMBA to DNA in mammalian cells through the use of antibodies against specific cytochrome P-450 isozymes; 2) To continue the development of a lambda35S-ATP postlabeling procedure to allow detection of unlabeled hydrocarbon-DNA adducts at low levels with the advantages of analysis at the mononucleotide level by HPLC and the use of 35S rather than 32P. This assay will be used to facilitate studies in activator and target cells under conditions of mutation assays; 3) To investigate the binding of DMBA and B(a)P to specific regions of chromatin and DNA in cells from various species through the use of immunoaffinity chromatography on columns prepared with antibodies against DMBADE-DNA adducts and B(a)P-DNA adducts; 4) To determine the role of base sequence in the binding of DMBA and B(a)P to DNA through the use of defined sequence oligonucleotides produced by PCR; 5) To determine the relationship of DMBA and B(a)P adduct formation to the formation of oxidative damage as measured by formation of 8-hydroxy-dG in DNA in mammalian cells; 6) To relate the binding of B(a)P and DMBA to DNA to produce specific adducts or to specific regions of DNA and chromatin to mutation induction in cell-mediated V79 cell assays.
|Floyd, Robert A (2009) Serendipitous findings while researching oxygen free radicals. Free Radic Biol Med 46:1004-13|
|Baird, William M; Hooven, Louisa A; Mahadevan, Brinda (2005) Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ Mol Mutagen 45:106-14|
|Okazaki, Takao; Laali, Kenneth K; Zajc, Barbara et al. (2003) Stable ion study of benzo[a]pyrene (BaP) derivatives: 7,8-dihydro-BaP, 9,10-dihydro-BaP and its 6-halo derivatives, 1- and 3-methoxy-9,10-dihydro-BaP-7(8H)-one, as well as the proximate carcinogen BaP 7,8-dihydrodiol and its dibenzoate, combined with a co Org Biomol Chem 1:1509-16|
|Mahadevan, Brinda; Dashwood, Wan-Mohaiza; Luch, Andreas et al. (2003) Mutations induced by (-)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo[a,l]pyrene in the coding region of the hypoxanthine phosphoribosyltransferase (Hprt) gene in Chinese hamster V79 cells. Environ Mol Mutagen 41:131-9|
|Buters, Jeroen T M; Mahadevan, Brinda; Quintanilla-Martinez, Leticia et al. (2002) Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation. Chem Res Toxicol 15:1127-35|
|Mahadevan, B; Luch, A; Seidel, A et al. (2001) Effects of the (-)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo. Carcinogenesis 22:161-9|
|Melendez-Colon, V J; Luch, A; Seidel, A et al. (2000) Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures. Chem Res Toxicol 13:7-Oct|
|Melendez-Colon, V J; Luch, A; Seidel, A et al. (1999) Comparison of cytochrome P450- and peroxidase-dependent metabolic activation of the potent carcinogen dibenzo[a,l]pyrene in human cell lines: formation of stable DNA adducts and absence of a detectable increase in apurinic sites. Cancer Res 59:1412-6|
|Luch, A; Kishiyama, S; Seidel, A et al. (1999) The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1. Cancer Res 59:4603-9|
|Luch, A; Kudla, K; Seidel, A et al. (1999) The level of DNA modification by (+)-syn-(11S,12R,13S,14R)- and (-)-anti-(11R,12S,13S,14R)-dihydrodiol epoxides of dibenzo[a,l]pyrene determined the effect on the proteins p53 and p21WAF1 in the human mammary carcinoma cell line MCF-7. Carcinogenesis 20:859-65|
Showing the most recent 10 out of 38 publications